Wilson Sonsini Advises Beren Therapeutics P.B.C. on $300 Million Financing, Including Equity and Debt and Royalty Facilities
Biotech
Our Industry Coverage
Innovative and passionate; that's how we describe our biotech companies. From cutting-edge biopharmaceutical therapies to bioinformatics, we support our clients’ pursuit of excellence. Through their relentless drive to innovate, we work to protect pivotal intellectual property, navigate regulatory environments, and advise on financing strategy.
Industry Highlights
Celebrating our founders’ successes
2026
Cognito Therapeutics Announces Oversubscribed $105 Million Series C
Neurotechnology2026
Soley Therapeutics Announces $200 Million Series C Financing
Biotechnology, Drug Discovery2025
Foresight Diagnostics Announces Acquisition by Natera
Cancer Diagnostics2025
Denali Therapeutics Announces $200 Million Public Offering
Biopharmaceutical, Biotechnology2025
Enliven Therapeutics Announces $230 Million Public Offering
Biopharmaceutical2024
Kumquat Biosciences and Takeda Enter into Strategic Collaboration and Global License Agreement
Biotechnology2023
DTx Pharma Announces Acquisition by Novartis
Biotechnology2023
XinThera Announces Acquisition by Gilead Sciences
Biotechnology2023
Aspect Biosystems Announces $2.7 Billion Collaboration with Novo Nordisk
Biotechnology2022
Tenaya Therapeutics Raises Approximately $75 Million in Public Stock Offering
Biotechnology2022
GSK Completes Acquisition of Sierra Oncology
Biopharmaceutical2022
Arcellx, Inc. Raises $124 Million IPO
Biotechnology2021
Ventyx Biosciences Closes IPO at $175 Million
Biotechnology, Pharmaceuticals2021
Tenaya Therapeutics Completes IPO Worth $207 Million
Biotechnology2021
Kinnate Biopharma Inc. Raises $276 Million IPO
Drug Discovery, Pharmaceuticals2020
ALX Oncology Holdings Inc. Closes IPO at $186 Million
Immuno-Oncology2020
ORIC Pharmaceuticals Raises $138 Million IPO
Pharmaceuticals2020
Applied Molecular Transport Closes IPO at $154 Million
Pharmaceuticals2019
IGM Biosciences Launches IPO
BiotechnologyAttorneys
focused
on this
industry
recent news
we want to share
with you
Wilson Sonsini Advises Isomorphic Labs on $2.1 Billion Series B Investment Round
Wilson Sonsini Advises Isomorphic Labs on $2.1 Billion Series B Investment Round
Client Highlights06/03/26
Wilson Sonsini Represents Investors in Windward Bio’s $165 Million Crossover Financing
Wilson Sonsini Represents Investors in Windward Bio’s $165 Million Crossover Financing
Client Highlights05/05/26
Wilson Sonsini Advises Novo Holdings, Norwest, and Platanus on Ray Therapeutics’ $125 Million Series B